Q4 2024 Earnings Call Transcript February 7, 2025 Operator: Good morning, all, and thank you for joining us for the CNO ...

Hims is a US-based telehealth company offering online prescription medication, over-the-counter drugs, and personal care ...

CFRA analyst Catherine Seifert upgraded Allstate's stock rating from 'Buy' to 'Strong Buy', maintaining a price target of $230.00. Seifert's valuation of Allstate (NYSE: ALL) shares is based on a ...